BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 6774459)

  • 1. Effects of continuous treatment with superagonists of LHRH when initiated at different times of the menstrual cycle in female baboons.
    Vickery BH; McRae GI
    Int J Fertil; 1980; 25(3):171-8. PubMed ID: 6108925
    [No Abstract]   [Full Text] [Related]  

  • 2. Mid-cycle contraception with LHRH in women.
    Maia H; Barbosa IC; Maia H; Coutinho EM
    Reproduccion; 1981; 5(4):251-60. PubMed ID: 7033017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal LHRH agonist treatment for inhibition of ovulation in women: clinical aspects.
    Bergquist C; Nillius SJ; Wide L
    Clin Endocrinol (Oxf); 1982 Jul; 17(1):91-8. PubMed ID: 6811167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the intranasal administration of LHRH superanalogue on endogenous LHRH in humans.
    Matsubara M; Koyanagawa Y; Nakagawa K
    Horm Metab Res; 1989 Feb; 21(2):104-5. PubMed ID: 2498194
    [No Abstract]   [Full Text] [Related]  

  • 5. [Luteolytic action of LHRH in women].
    Lemay A; Labrie F; Azadian-Boulanger G; Raynaud JP
    C R Acad Hebd Seances Acad Sci D; 1978 Feb; 286(7):527-9. PubMed ID: 95893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of amenorrhea with a LH-RH-analogue as nasal spray].
    Friedrich F; Kemeter P
    Wien Med Wochenschr; 1982 Jan; 132(1):19-21. PubMed ID: 6803443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of plasma progesterone, oestradiol-17beta and cortisol in ovulatory response to gonadotropin-releasing hormone in dairy cows with cystic follicles.
    Isobe N; Yamada K; Yoshimura Y
    Reprod Domest Anim; 2007 Aug; 42(4):370-5. PubMed ID: 17635773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of a single intranasal administration of [D-Ser(TBU)6, des-Gly-NH210]LHRH ethylamide, a potent LHRH agonist, on serum steroid levels in normal adult men.
    Bélanger A; Labrie F; Lemay A; Caron S; Raynaud JP
    J Steroid Biochem; 1980 Feb; 13(2):123-6. PubMed ID: 6770199
    [No Abstract]   [Full Text] [Related]  

  • 9. LHRH analogues for contraception.
    Lancet; 1987 May; 1(8543):1179-81. PubMed ID: 2883492
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic treatment with a LH-RH-agonist: a new contraceptive method?
    Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Nevinny-Stickel J
    Acta Eur Fertil; 1981 Sep; 12(3):275-6. PubMed ID: 6803498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Variations in the plasmatic concentration of progesterone in the post-ovulatory phase of the normal menstrual cycle].
    Falsetti L; Viani A; Tassi PG
    Ann Ostet Ginecol Med Perinat; 1975; 96(5):327-33. PubMed ID: 1220598
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of apoptosis by AN-152, a cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), in LHRH-R positive human breast cancer cells is independent of multidrug resistance-1 (MDR-1) system.
    Günthert AR; Gründker C; Bongertz T; Nagy A; Schally AV; Emons G
    Breast Cancer Res Treat; 2004 Oct; 87(3):255-64. PubMed ID: 15528968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin determinations in timed 3-hour urine collections during the menstrual cycle and LHRH testing.
    Beitins IZ; O'loughlin K; Ostrea T; Mcarthur JW
    J Clin Endocrinol; 1976 Jul; 43(1):46-55. PubMed ID: 12258903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle arrest in endometrial carcinoma cells exposed to gonadotropin-releasing hormone analog.
    Kim JW; Lee YS; Kim BK; Park DC; Lee JM; Kim IK; Namkoong SE
    Gynecol Oncol; 1999 Jun; 73(3):368-71. PubMed ID: 10366462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of luteal function after administration of D-leu6 ethylamide in cyclic women.
    Scarselli GF; Campana A; Franchini M; Eppemberger U; Klapan E; Bigazzi M; Noci I
    Acta Eur Fertil; 1981 Sep; 12(3):285-6. PubMed ID: 6803501
    [No Abstract]   [Full Text] [Related]  

  • 16. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.
    Günthert AR; Gründker C; Bongertz T; Schlott T; Nagy A; Schally AV; Emons G
    Am J Obstet Gynecol; 2004 Oct; 191(4):1164-72. PubMed ID: 15507937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacologic suppression of the ovarian function and its clinical usefulness].
    Kershenovich Sefchovich R; Kably Ambe A; García Morales MA; Peryra Quiñones R; Barrón Vallejo J
    Ginecol Obstet Mex; 1997 Aug; 65():344-8. PubMed ID: 9324471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of prolactin release by LRF and LRF-agonist.
    Yem SS; Hoff JD; Lasley BL; Casper RF; Sheehan K
    Life Sci; 1980 Jun; 26(23):1963-7. PubMed ID: 6995765
    [No Abstract]   [Full Text] [Related]  

  • 19. [Regulation of the menstrual cycle by post-ovulatory administration of LHRH or an agonistic LHRH analog in the normal woman].
    Lemay A; Labrie F; Raynaud JP
    Union Med Can; 1980 Feb; 109(2):240-5. PubMed ID: 6774459
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.